Manuel De Jesus: Innovating Anemia Monitoring Through Biomedical Engineering and Digital Technology
Manuel De Jesus, Trainee in Polymer Sciences and Advanced Materials at the Center for Graduate Studies and Research in Chemistry (CGIQ), shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in CNE Fortbildung, adding:
”The integration of engineering, biomedical analysis, and digital technology is opening new possibilities for accessible and portable healthcare solutions.
I’m pleased to share our scientific article:
‘Comprehensive Development and Evaluation of a Portable Medical Device with a Digital Monitoring Platform for Anemia Based on Blood Viscosity Analysis.’ — August 2026
This work presents the development and evaluation of a portable medical device and digital monitoring platform for anemia assessment based on blood viscosity analysis, integrating physical measurement, electronic instrumentation, and digital data monitoring.
The project explores how engineering and digital technologies can contribute to the development of accessible, portable, and efficient tools for health monitoring.
From blood analysis to digital innovation, engineering can transform scientific concepts into practical solutions for healthcare.”
Title: Comprehensive Development and Evaluation of a Portable Medical Device with a Digital Monitoring Platform for Anemia Based on Blood Viscosity Analysis
Authors: Manuel De Jesus Cardenas Medina, Moisés I. Salazar G., Alberto Cabrera, Daniel Chávez
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 3, 2026, 16:10Tanzeel Alamin Almahdi Gorashi: NLR as an Accessible Biomarker for Monitoring Pediatric Sickle Cell Anemia
-
Sep 3, 2026, 15:37Hadis Nabipoor: QICL2026 Highlights the Critical Importance of Transfusion Safety
-
Sep 3, 2026, 15:32Gopal Patidar: The ISBT Haemovigilance Working Party Sharing Knowledge and Promoting Best Practices
-
Sep 3, 2026, 15:24Bhalchandra Kawdikar: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 15:18Massimo Martino: Redefining Allogeneic Transplantation in Myelofibrosis
-
Sep 3, 2026, 15:10Tvisha Subhasish: Extravascular Factor IX Beyond the Circulation
-
Sep 3, 2026, 11:21Thrombotic Microangiopathies: From Clinical Syndrome to Molecularly Targeted Therapy
-
Sep 3, 2026, 10:56Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?
-
Sep 3, 2026, 10:42Jared Griffard: Hemorrhagic Shock and Component Blood Transfusion